Einat Brill Almon
2019
In 2019, Einat Brill Almon earned a total compensation of $422.2K as Senior Vice President, Product Development at Protalix BioTherapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Option Awards | $93,916 |
|---|---|
| Salary | $251,509 |
| Other | $76,756 |
| Total | $422,181 |
Almon received $251.5K in salary, accounting for 60% of the total pay in 2019.
Almon also received $93.9K in option awards and $76.8K in other compensation.
Rankings
In 2019, Einat Brill Almon's compensation ranked 12,211th out of 13,971 executives tracked by ExecPay. In other words, Almon earned more than 12.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,211 out of 13,971 | 13th |
Division Manufacturing | 4,948 out of 5,701 | 13th |
Major group Chemicals And Allied Products | 1,949 out of 2,200 | 11th |
Industry group Drugs | 1,679 out of 1,886 | 11th |
Industry Biological Products, Except Diagnostic Substances | 365 out of 389 | 6th |
Source: SEC filing on April 15, 2020.
Almon's colleagues
We found six more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2019.
2019
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2019
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2019
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
2019
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
2019
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2019
Eyal Rubin
Protalix BioTherapeutics